Indivior Pharmaceuticals (INDV) Interest Expenses (2022 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Interest Expenses of $14.0 million for Q1 2026, up 16.67% year-over-year from $12.0 million in Q1 2025, and up 133.33% quarter-over-quarter from $6.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Interest Expenses (2022 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Interest Expenses history runs 5 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 16.67% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $14.0 million (down 68.89% YoY), while the FY2025 annual figure was $55.0 million, up 17.02% from the prior year.
- Interest Expenses for Q1 2026 stood at $14.0 million, up from $6.0 million in the prior quarter.
- The five-year high for Interest Expenses was $28.0 million in Q4 2023, with the low at $6.0 million in Q4 2025.
- The 5-year median for Interest Expenses is $12.0 million (2025), against an average of $13.8 million.
- Peak annual rise in Interest Expenses reached 66.67% in 2025, while the deepest fall reached 53.85% in 2025.
- Indivior Pharmaceuticals' Interest Expenses stood at $23.0 million in 2022, then gained by 21.74% to $28.0 million in 2023, then plunged by 53.57% to $13.0 million in 2024, then tumbled by 53.85% to $6.0 million in 2025, then soared by 133.33% to $14.0 million in 2026.
- Business Quant data shows INDV's Interest Expenses at $14.0 million in Q1 2026, $6.0 million in Q4 2025, and $12.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.00 Mn |
| Jun 30, 2026 | 13.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |